Studies carried out with tracer doses of radiostrontium (Sr85) in man have revealed qualitative similarities but quantitative differences in metabolism of strontium and calcium (1-5). The principle of qualitative correlation between urinary excretion of calcium and of radiostrontium has been utilized in investigations of the removal of radiostrontium from man (6). It has been shown that elimination of radiostrontium could be considerably enhanced by inducing an increase of urinary calcium excretion, either by intravenous administration of calcium or by use of the combination of both agents (6). A study was then initiated to investigate the effect of orally administered calcium and of the duration of calcium supplementation on radiostrontium metabolism in man. It was hoped that prolonged oral administration of calcium would lead to a decrease in radiostrontium body burden by decreasing absorption of radiostrontium from the intestinal tract and by increasing its excretion via the kidney due to the concomitant increase of urinary calcium excretion during the phase of high calcium intake. Some of the data on the effect of high calcium intake on Sr85 metabolism in man has been preliminarily presented (7), and the results obtained in these and in additional studies are reported in this communication.
Studies carried out with tracer doses of radiostrontium (Sr85) in man have revealed qualitative similarities but quantitative differences in metabolism of strontium and calcium (1) (2) (3) (4) (5) . The principle of qualitative correlation between urinary excretion of calcium and of radiostrontium has been utilized in investigations of the removal of radiostrontium from man (6) . It has been shown that elimination of radiostrontium could be considerably enhanced by inducing an increase of urinary calcium excretion, either by intravenous administration of calcium or by use of the combination of both agents (6) . A study was then initiated to investigate the effect of orally administered calcium and of the duration of calcium supplementation on radiostrontium metabolism in man. It was hoped that prolonged oral administration of calcium would lead to a decrease in radiostrontium body burden by decreasing absorption of radiostrontium from the intestinal tract and by increasing its excretion via the kidney due to the concomitant increase of urinary calcium excretion during the phase of high calcium intake. Some of the data on the effect of high calcium intake on Sr85 metabolism in man has been preliminarily presented (7) , and the results obtained in these and in additional studies are reported in this communication.
MATERIALS AND METHODS
Carrier-free Sr', a y-emitter which has a half-life of 65 days, was administered as the chloride by the intravenous or oral route to 14 patients who were studied under controlled dietary conditions (8) on the Metabolic Research Ward.
All patients were in good physical condition; 11 were fully ambulatory and 3 were semiambulatory (Patients 6, 12, 13) . The patients received no medication during the tracer studies except Patient 1 who received 50 tug of an estrogen analog1 (9) during the entire course of the study.
The diet was a constant, analyzed low calcium diet which contained an average of 1,850 calories, 68 g protein, 265 g carbohydrate and 59 g fat, 150 mg calcium and 700 mg phosphorus per day. The fluid intake was kept constant during the entire study and the body weight was determined daily. In studies carried out in the high calcium phase, the calcium intake was raised by adding calcium gluconate tablets to the low calcium diet.
All other constituents of the diet were kept constant. The Ca: P ratio was approximately 1: 4 during low calcium intake and averaged 2: 1 during high calcium intake.
All patients received tracer doses of Sr' during low and high calcium intake; 3 received Sr' intravenously, 3 received the tracer intravenously and orally at different times, and 8 received the tracer orally during the phase of low and high calcium intake. Sr's studies carried out during low calcium intake preceded those performed during high calcium intake except in Patients 4 and 5 in whom the low calcium studies were performed 11 months after the high calcium intake had been discontinued. Table I lists the patients studied, the diagnoses, and duration of the radiostrontium studies carried out during low and high calcium intake. The amount of calcium added to the diet and the duration of calcium supplementation prior to the Sri' studies performed during high calcium intake are also listed in this table.
Calcium supplements were continued throughout the Sr' studies during the high calcium phase. Tracer doses of Sr" were given intravenously at different time intervals during high calcium intake to Patients 3 and 5, and orally to Patients 7 and 8 in order to investigate whether the duration of high calcium intake affected radiostrontium absorption and excretion.
The dose of Sr8" ranged from 0.2 to 0.4 juc per kg body weight. After intravenous injection or oral ingestion of a single dose of the radioisotope, samples of plasma were obtained for Sr85 analyses at 1, 4, 8 and 24 hours on the first day of each study. Subsequently, Sr'-' plasma levels were determined daily for 6 days, and 3 times per week thereafter for as long as significant counts could be obtained with the equipment available. On the day of each tracer study, the 24-hour urine output was fractionated at time intervals at which plasma samples were (3) .
Balances of nitrogen, calcium, and phosphorus were performed during each tracer study to determine the metabolic status of the patients and to correlate changes in calcium metabolism during high calcium intake with data obtained in Sr85 studies in this phase.
Metabolic balances were determined by analyzing aliquots of 6-day pools of urine and stool and aliquots of the diet. Urinary and fecal nitrogen were analyzed by the Kjeldahl method, phosphorus by the method of Fiske and Subbarow (8) , urinary calcium by the method of Shohl and Pedley (9) . Stool calcium and phosphorus were determined on ashed aliquots of 6-day collection pools. The technique of intravenous and oral administration of Sr"5 and of Sr85 analyses of plasma, urine and stool have been described in previous communications (3, 6 ). Table II shows data on urinary and fecal Sr85 excretions and on Sr85 body retention of 6 patients after intravenous administration of the tracer during low and high calcium intake. Urinary Sr85 excretion was higher during high than low calcium intake except for Patient 3 (second study) and Patient 6. This increase ranged from 7.9 to 14.0 per cent. No appreciable change in fecal Sr85 was noted during low and high calcium intakes. Increased urinary Sr85 excretion was accompanied by an increase of calciuria and by a decrease of Sr85 body retention, which ranged from 5. (13) . Whether the effect of high calcium intake in rats is due to species differences or to the very high dietary calcium intake (13) , as compared with that used in the present study in man, is not certain.
RESULTS
The results obtained in man are in agreement with studies carried out in mature rats (14) (15) (16) . Varying calcium intake levels used in studies of Sr90 bone retention in mature rats (14) have revealed an inverse relationship between dietary calcium intake and bone retention of Sr90 and Ca45, but the concentration of Sr90 decreased less than that of Ca45 when the diet was supplemented with calcium. In other experiments (15) , increased calcium intake had no effect in decreasing the concentration of Sr90 in bone, while that of Ca45 decreased approximately 50 per cent; these investigators pointed out that factors other than calcium, such as the level of phosphate and carbonate in the diet, may influence Sr90 uptake by bone. The radiostrontium body burden could be reduced in immature rats by increased dietary calcium intake, whether the phosphorus intake was low or high, while similar results could be obtained in mature rats only when dietary calcium and phosphorus intake were raised simultaneously (16). Copp and co-workers have demonstrated that urinary and fecal radiostrontium excretions could be increased in rats receiving a phosphorusdeficient diet (11). Cramer and Copp (17) later showed that urinary excretion of radiocalcium of both young and old rats may remain high on phosphorus-deficient diets regardless of the level of calcium intake, and that radiostrontium excretion of young rats increased during low phosphorus intake. MacDonald and co-workers have shown that the Sr90 body burden of rats could be reduced by increasing dietary calcium and the body burden could be further decreased by increasing the phosphorus content (12). SUMMARY 1. The effect of high calcium intake of varying duration was studied on radiostrontium (Sr85) metabolism in 14 patients under controlled dietary conditions. The calcium intake of 10 patients was approximately 10 times as high during high as during low calcium intake.
2. Tracer doses of Sr85 were given orally or intravenously in separate studies during low and high calcium intake to the same subject.
3. The intestinal absorption of orally administered tracer doses of Sr85 was of similar magnitude during low and high calcium intake in 7 of 11 patients and was lower in 4 patients during high than during low calcium intake.
4. The addition of calcium to the diet resulted in increased urinary excretion of calcium in most patients. This increase was accompanied by a somewhat higher excretion of radiostrontium after intravenous doses of Sr85 in 4 of 6 patients, while in general, no increase of urinary Sr85 excretion occurred when Sr85 was given orally.
